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Summary.-Autopsy records based on 647 primary carcinomata of the breast
provided the data to describe a few possible routes of dissemination of cancer of the
breast. Calculations were made to test whether the hypothesis of a multistep
dissemination of the tumour from the primary site was likely. A multistep dis-
semination means that the presence of metastases at peripheral sites is influenced
by the presence of the tumour in 3 organs, i.e. lungs, liver and bones, very often
seeded by the primary cancer.
Several interpretations are discussed, with emphasis on those findings which
could be explained in terms of a haematic route of dissemination or in terms of an
anatomical proximity.
BROADLY speaking, the disseminationi
of cancer can occur by either of two
general processes. The first is a one-step
process in which the cancer cells are
disseminated directly from the primary
to metastatic sites throughout the body.
The second is a multi-step or " cascade"
process in which a relatively few meta-
stases are produced by the primary but
these metastases give rise to other meta-
stases. While both processes may occur
for cancers at a given site, it is of both
scientific and clinical imnportance to obtain
a clearer picture of which process is
predominant and what sequence of sites
is involved in the cascade process. The
purpose of this paper is to analyse 647
autopsy reports on metastases in patients
with breast cancer from the Roswell Park
Memorial Institute Department of Patho-
logy, in order to clarify the metastatic
processes at this site.
MATERIALS AND METHODS
Each autopsy record included the age in
years at death, sex and race, duration of the
disease in months and a detailed description
of the various organs containing metastases
from the primary tumour. Organs wrere
omitted from this study when the frequency
of their being seeded wNas below 10%. The
3 organs most frequently seeded were the
bones, lungs and liver. These 3 sites were
classified as " major ones ". All the per-
centages in Table I were calculated by using
647 as the over-all total, with only a few
exceptions (specified). An analysis of vari-
ance was carried out using occurrence or
non-occurrence of lung, liver and bone
metastases as a 23 factorial design.
The term " effect " in the factorial design,
such as lung-effect etc., should be interpreted
as ifthe presence ofthe primary cancer in the
lungs acted as a new source of dissemination
ofthe cancer in relation to other sites. Later
on it will be discussed how justifiable it is to
label the lungs, liver and bones as " main
effects ". The amount of variation attri-
butable to every main effect and related
interaction was calculated.
Two organs belonging to the endocrine
system, i.e., ovaries and adrenals, were
omitted from the final analysis because almost
one quarter of the patients were either
adrenalectomized or ovariectomized. The
inclusion of those 2 sites might have intro-
duced a selection bias.
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RESULTS
Table I gives the percentages of meta-
stases at peripheral sites including 3
lymphatic areas, i.e. neck, thorax and
abdomen. Four sites belong to the endo-
crine system, i.e. pituitary and/or para-
thyroid, thyroid, ovaries and adrenals.
The majority of the other sites are
abdominal, such as the stomach, kidney,
pancreas and peritoneum. The lungs,
liver and bones, with a metastatic fre-
quency of0-66, 0-61, and 0 70 respectively,
were considered to be potential sources of
further metastatic dissemination because
these 3 sites are most often seeded by
cancer of the breast. The axillary lymph
nodes, which very often represent the
first area seeded by the mammary tumour,
were not considered in this study because
at the time of autopsy they were already
removed by the surgical treatment. The
lymph nodes of the thorax (0.56) were
not taken into account as a possible source
of a further metastatic spread to other
sites because their seeding is almost always
associated with the presence of metastases
in the lungs, i.e. the lungs represent a
more general source of potential meta-
stases.
Table II shows a very striking feature
in the first column: the low frequency of
metastases in various sites, with the
exception of the central nervous system
(0a13), when the 3 major sites are not
seeded. Looking at the rows of Table II,
2 main features appear. The frequency
of metastases increases as soon as one or
more of the 3 major sites are seeded by
the primary tumour. For certain distal
sites the effect of one or 2 of the major
TABLE I.-Number and Percentage of Cases with Metastases Reported on Autopsy at a
Given Site (647 Primary Carcinomata of the Breast)
Site No. % Site No. %
Stomach . 62 . 10 . Lymph nodes: neck . 233 . 36
Pancreas . 70 . 12 . Lymph nodes: thorax . 359 . 56
Liver . 397 . 61 . Lymph nodes: abdomen 250 . 38-5
Lungs . 401* . 66t Lymph nodes: pelvis . 107 . 16-6
Bones . 450 70 . Pituitary and/or parathyroid . 130 . 20
Uterus . 86 . 13 Adrenals . 176 . 38t
Peritoneum . 156 . 24 . Thyroid . 132 . 20
Kidney . 86 . 13 . Ovaries . 61 . 15t
Central nervous system . 161 . 25
* Excluding case not reported (33 cases).
t Excluding adrenalectomized or ovariectomized patient (248 cases).
TABLE II.-Percentage of Metastases at Minor Metastatic Sites by Status at 3 Major Sites
Major site
Lung
Liver
Bones
Number within statusa
% with status
Minor site
Pituitary
Ovary
Central nervous system
Adrenals
Stomach
Pancreas
Kidney
Uterus
Thyroid
Status at major metastatic site
_ _ _ - ± + ± ±
- + ± - ± +
_ ± - ± - + - ±
90 33 12 70 36 74 37 249
15 5 2 12 6 12 6 41
2
1
13
2
3
1
2
3
2
9
17
21
35
21
6
9
24
3
601 (total)
Percentage reported on autopsy
0.5 19 5 21 5 33
50 16 3 16 24 23
25 16 23 33 30 32
44 31 19 39 50 62
17 14 3 11 8 10
17 9 10 11 30 18
9 7 5 14 19 18
9 18 5 17 12 17
8 16 10 31 22 42
(-) Absence ofmetastases; (+) Presence ofmetastases.
a Number of patients in each of the 8 possible combinations of occurrence at major sites.
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TABLE III.-Sums ofSquares Performed on Table II of the Effect of 3 Major Metastatic
Sites (Lungs, Liver, Bones) and Related Interactions on the Frequency of Metastases
at MinorMetastaticSites
Minor metastatic sites
5~~~~~~~~~~
Effect Pituitary CNS Stomach
Lungs (A) . 0-0141 0-0231 0 0066
Liver (B) . 0-0052 0-0021 0-0015
Bones (C) . 0-0604 0-0015 0-0078
AxB . 0-0001 0.0000 0-0001
AxC . 0 0043 0-0021 0 0003
BxC . 0.0069 0 0078 0-0091
AxBxC 0.0000 0-0010 0 0028
Total . 00909 0 0376 0 0282
TABLE IV.-Percentages of the Total Variation on the Frequency
Metastatic Sites for the Main Effect and Interactions of 3
(Lungs, Liver, Bones) and Related Interactions*
Minor metastatic sites
Pituitary
15
6
66
0-1
5
8
0.0
CNSb Stomach P
61 23
6 5
4 28
6 04
21
3
0.0
1
32
10
'ancreas Kidney Uterus
29 41 0-3
48 25 3
5 8 77
1 8 2
1 0*4 6
16 17 13
0.0 0.0 0-8
* This table was obtained from Table III, by dividing each entry by its column total.
b Central nervous system.
TABLE V.-F Values from Analysis of Variance Performed on Table III
with 28 D.F. and 1 D.F. for Each Main Effect) (Pooled Error
Minor metastatic sites
Effect of A
major site Pituitarya CNSb Stomach Pancreas Kidney Uterus Thyroid
Lungs . 5.38*
Liver . 2-00
Bones . 23.23t
* F probability < 0 05.
t F. probability,-.., 0
- 01.
a And/orparathyroid.
b Central nervous system.
8.88t 2 54 6 23t 4*04 0 04
0.81 0*57 1019t 2 54 023
058 3*00 0*96 0 81 10.62t
sites seems to be paramount. Examples
are bones for the pituitary (0.19), liver
for ovary (0.50), liver and bones for
adrenals, liver and lungs for pancreas and
bones for uterus.
Table II was analysed as a 23 factorial
design whose sums of squares are shown
in Table III. The total sum of squares
was calculated for each column. Table
IV was obtained by dividing each entry
in Table III by the column total.
The highest percentage of the total
27 76t
8 50t
12-03t
variation for the pituitary gland is due
to the bones (0.66) followed by the lungs
(0.15). When metastases are present in
the central nervous system, 0-61 of the
total variation is attributable to the lungs
and a (liver x bones) interaction term
accounts for 0-21 ofthe total variation.
The stomach shows a rather erratic
pattern; the liver effect explains almost
one half (0.45) of the pancreas variation,
followed by the lungs effect; the opposite
holds true for kidney; the relationship
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Pancreas
0-0162
0 0265
0*0025
0*0008
0-0008
0- 0085
00000
0*0553
Kidney
0-0105
0-0066
0-0021
0-0021
00001
0-0045
00000
0 0259
Uterus
0*0001
0*0006
0 0276
0 0006
0-0021
0 0045
0 0003
0 0358
Thyroid
0 0722
0-0221
0-0313
0 0002
0-0198
0*0005
0*0008
0-1400
Effect
Lungs (A)
Liver (B)
Bones
A x B
B x C
A x C
A x B x C
of Metastases at Minor
Major Metastatic Sites
Thyroid
52
16
22
0-1
9
04
0-6
tSOME ROUTES OF DISSEMINATION OF CANCER OF THE BREAST
between uterus and bones seems to be
paramount (0.77) and the thyroid seems
to be more often related to the lungs
(0 52), followed by the bones (0.22) and
liver (0-16). With the exception of thy-
roid (Table V), no site has significant F
values for all 3 main effects.
The pituitary gland shows 2 significant
F values due to the lung and bone
" effects ". The central nervous system
is related to the lungs; pancreas has a
double association, i.e. with lungs and
liver, the uterus is significantly related to
the bony system; F values for the kidney
are significant, although the biggest effect
is due to the lungs, the second one to the
liver and the third one, due to the bones,
is negligible. The stomach is quite similar
to the kidney, with the only exception of
the " liver effect " which appears to be
negligible.
DISCUSSION
Because lungs, liver and bones have a
high frequency of metastases, it is not
possible to say whether these 3 major
metastatic sites are independently seeded
by the primary tumour, or whether they
influence each other. It seems unlikely,
however, that less frequently seeded sites
produce metastases in the lungs, liver and
bones (Table II).
There are two interpretations of the
term "effect ", used in the factorial
design: the " single effects " of the fac-
torial design could be interpreted either
as a real dissemination of metastases
from major sites to minor ones, or as a
measure of the strength of the association
between 2 organs seeded by the primary
tumour. Indeed, autopsy findings do not
indicate any time sequence related to the
appearance of metastases in different
organs. If, for example, lung metastases
do not shorten the life span of a patient
excessively, the " lung effect " on pancreas
would be just a " time effect" long
enough so that metastases can reach the
pancreas and can therefore proliferate for
a long enough period to be detected.
If such an explanation were true, one
would expect everywhere in Table V a
pattern like that shown by the thyroid,
where all the 3 single effects are significant
at below 5 % probability level. Instead,
Table V shows that the pattern of the
significant F values is different for differ-
ent secondary sites. The pattern can be
interpreted either in terms of an anatomi-
cal proximity, such as liver and pancreas,
or in terms ofa " blood vessel " metastatic
dissemination, such as the lungs and the
central nervous system. Either route
strongly supports the hypothesis of a
multistep dissemination.
It appears (Table V) that the lungs
tend to release metastases into the circu-
latory system (distant metastases), such
as the central nervous system, pancreas,
pituitary and thyroid. An intra-abdomi-
nal, probably lymphatic dissemination of
metastases, from the liver to the pancreas,
is plausible (multistep lymphatic). The
relationship between liver and thyroid is
also rather obscure.
The osseous system seems to affect
various sites, a few of which are related
only to the bones, i.e. uterus, and a few
others are in common with the other 2
major sites, i.e. pituitary and/or para-
thyroid, and thyroid. This seems to
imply, first of all that the osseous system
can release metastases into the blood
stream which can affect various organs
without any filtering effect exerted by the
lungs, i.e. with no appearance of meta-
stases in the lungs. The osseous system
was subdivided into 2 parts-vertebrae
(64.9) and others (55.8); therefore, a
certain ambiguity might arise in dealing
with bones and related peripheral sites
because it was not specified which bone
was affected by metastases. For kidneys
and stomach, none of the F values were
significant at the 5% probability level;
this simply means that it is not possible
to establish any route of dissemination
of the tumour to the two aforementioned
peripheral organs with these data.
Table IV is in good agreement with the
results of Table V. There is a satisfac-
339340 E. VIADANA, I. D. J. BROSS AND J. W. PICKREN
tory correspondence between the signifi-
cant F values and the highest proportions
of the total variation due to single effects
(Table IV).
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